Search Results 681-690 of 17036 for Hepatitis b

1. A Study to Evaluate the Safety, Tolerability and Metabolism of BIIB105 in Subjects with Amyotrophic Lateral Sclerosis - Mayo Clinic

   - Current hepatitis C infection. - Current hepatitis B infection. - History of alcohol or substance abuse ≤6 months of Screening that would limit

2. Study of Veltuzumab and 90Y-Epratuzumab in Relapsed/Refractory, Aggressive NHL - Mayo Clinic

   ... (hepatitis B surface antigen/antibodies, core antigen/antibodies, hepatitis B e-antigen). Patients of childbearing potential must be willing to practice ...

3. Chemoradiation With or Without Atezolizumab in Treating Patients With Limited Stage Small Cell Lung Cancer - Mayo Clinic

   Active hepatitis B (chronic or acute) or hepatitis C infection. Note that if hepatitis status is unknown, hepatitis B/C testing is required: Patients with ...

4. A Study Evaluating the Effectiveness of Axicabtagene Ciloleucel Compared to Standard of Care Therapy in Subjects with Relapsed/Refractory Diffuse Large B Cell Lymphoma - Mayo Clinic

   ... hepatitis C virus (anti-HCV positive). If there is a positive history of treated hepatitis B or hepatitis C, the viral load must be undetectable per ...

5. Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

   Serologic status reflecting active hepatitis B or C infection; patients that are positive for hepatitis B core antibody, hepatitis B surface antigen (HBsAg) ...

6. Dose Escalation Study in Patients With Relapsed or Refractory DLBCL and MyD88 L265P Mutation - Mayo Clinic

   ... B-cell (ABC) type of ... Has a positive test for human immunodeficiency virus (HIV-1 or -2) hepatitis C virus (HCV) or hepatitis B surface antigen (HBsAg) ...

7. A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03) - Mayo Clinic

   Has active or uncontrolled hepatitis B or C infection; subject is positive for hepatitis ... Subjects who have received hepatitis B vaccination with only ...

8. Hugo Botha, M.B., Ch.B. - Doctors and Medical Staff - Mayo Clinic

   2019. FellowshipClinician-Investigator Training Program, Mayo School of Graduate Medical Education, Mayo Clinic College of Medicine · 2017. FellowRST Behavioral ...

9. Nonalcoholic fatty liver disease - Symptoms and causes - Mayo Clinic

   In NAFLD, too much fat builds up in the liver. It is seen most often in people who are overweight or obese. NAFLD is becoming more common, especially in Middle ...

10. Ruxolitinib Phosphate (Oral JAK Inhibitor INCB18424) in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin Lymphoma - Mayo Clinic

    Known active hepatitis B or C, or human immunodeficiency virus (HIV) infection; Subjects who, in the opinion of the Investigator, are unable or unlikely to ...